Lung Response to Inhaled Highly Toxic Chemicals
The summary for the Lung Response to Inhaled Highly Toxic Chemicals grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Lung Response to Inhaled Highly Toxic Chemicals: - The primary objective of this program announcement is to encourage research about how the upper respiratory tract and lungs respond to acute exposure to highly toxic chemicals and subsequent inhalation, so that preventive strategies can be improved, antidotes devised to lessen initial irritation of mucosal surfaces, mucosal absorption minimized, and acute lung injury causing pulmonary edema counteracted. This program encourages innovative, multidisciplinary basic and clinical research of the respiratory tract with the goal of accelerating progress in the diagnosis, prevention, and treatment of toxic inhalation from chemical exposures. - The PA will use the R01 grant mechanism - Eligible organizations include: For profit or non-profit organizations, public or private institutions, such as universities, colleges, hospitals, and laboratories, units of State and local government, eligible agencies of the Federal government, domestic institutions/organizations - Eligible principal investigators include all individuals with the skills, knowledge, and resources necessary to carry out the proposed research. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH programs. - There is no limit on the number of scientifically distinct applications that may be submitted. - The PHS 398 document is available at http://grants.nih.gov/grants/funding/phs398/phs398.html in an interactive format. For further assistance contact [email protected] Prospective applicants are urged to consult with the staff of the NHLBI early in the preparation of the application(see Section VII. Agency Contacts). - Telecommunications for the hearing impaired is available at: TTY 301-451-0088
|Federal Grant Title:||Lung Response to Inhaled Highly Toxic Chemicals|
|Federal Agency Name:||National Institutes of Health|
|Type of Opportunity:||Discretionary|
|Funding Opportunity Number:||PA-05-058|
|Type of Funding:||Grant|
|CFDA Descriptions:||Lung Diseases Research|
|Current Application Deadline:||No deadline provided|
|Original Application Deadline:||Multiple Receipt Dates - See Link to Full Announce|
|Posted Date:||May 25, 2005|
|Creation Date:||Jan 09, 2007|
|Archive Date:||Feb 03, 2007|
|Total Program Funding:|
|Maximum Federal Grant Award:|
|Minimum Federal Grant Award:|
|Expected Number of Awards:|
|Cost Sharing or Matching:||No|
- Applicants Eligible for this Grant
- Native American tribal organizations (other than Federally recognized tribal governments) City or township governments Native American tribal governments (Federally recognized) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled "Additional Information on Eligibility" for clarification) Special district governments County governments Public and State controlled institutions of higher education Private institutions of higher education Public housing authorities/Indian housing authorities State governments Small businesses Independent school districts For profit organizations other than small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Additional Information on Eligibility
- Eligible agencies of the Federal Government are eligible to apply. Foreign institutions are eligible to apply.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- Webmaster, NIH, Webmaster, Phone not available, Fax not available, Email [email protected] [email protected] Webmaster, NIH
- Similar Government Grants
- • Advancing Novel Research Models to Study Idiopathic Pulmonary Fibrosis (U01 Clinical Trial...
- • Management of Asthma in Primary Care - Bioinformatics Center (U24 - Clinical Trial Require...
- • Management of Asthma in Primary Care - Clinical Center (UG3/UH3 - Clinical Trial Required)
- • Molecular Atlas of Lung Development Program (LungMAP) Phase 2 - Data Coordinating Center (...
- • Molecular Atlas of Lung Development Program (LungMAP) Phase 2 - Human Tissue Core (U01- Cl...
- • Pathogenesis of Sars Lung Disease: in Vitro Studies and Animal Models
- • Protein Interactions Governing Membrane Transport in Pulmonary Health and Disease (R01)
- • Asthma Clinical Research Network
- More Grants from the National Institutes of Health
- • Ethical Issues in Translational Science Research (R01 Clinical Trial Optional)
- • A Collaborative Network to Optimize Emergency Care of Older Adults with Alzheimers Disease...
- • Innovations to Foster Healthy Longevity in Low-Income Settings (R03 Clinical Trial Not All...
- • HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Instit...
- • National Dental Practice-Based Research Network Clinical Trial or Observational Study Plan...